4//SEC Filing
Lavelle Erin 4
Accession 0001209191-22-055404
CIK 0001768446other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 7:08 PM ET
Size
5.7 KB
Accession
0001209191-22-055404
Insider Transaction Report
Form 4
Lavelle Erin
COO & CFO
Transactions
- Award
Stock Option (Right to Buy)
2022-10-31+170,000→ 170,000 totalExercise: $3.27Exp: 2032-10-30→ Common Stock (170,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of October 31, 2022 (the "2022 Vesting Commencement Date") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the 2022 Vesting Commencement Date.
Documents
Issuer
Eliem Therapeutics, Inc.
CIK 0001768446
Entity typeother
Related Parties
1- filerCIK 0001737613
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 7:08 PM ET
- Size
- 5.7 KB